VivoSeq
Other

Spinal Surgery

0

Pipeline Programs

2

Active Trials

2

Companies Involved

Spinal Surgery is an early-stage landscape with 0 programs across 2 companies. The most active players are Heron Therapeutics, Novo Nordisk.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

18

clinical trials

Completed13 · 72%
Unknown status3 · 17%
Recruiting2 · 11%

Trial Activity

18 trials

Vertebral Bone Marrow Clot for Spinal Surgery
Recruiting··N/A·NCT05947175·96 enrolled
HTX-011 in Spinal Surgery
Completed·HHeron Therapeutics·Phase 2·NCT04911062·32 enrolled
USG Guided ESP Block in Spinal Surgery
Completed··Phase 4·NCT04148729·40 enrolled
Use of Activated Recombinant FVII in Spinal Surgery
Completed·Novo Nordisk logoNovo Nordisk·Phase 2·NCT00102037·50 enrolled
Methadone and Ketamine for Spinal Surgery
Completed·EEndeavor Health·Phase 4·NCT02827526·130 enrolled
Methadone and Hydromorphone For Spinal Surgery
Completed·EEndeavor Health·Phase 4·NCT02107339·120 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)